Deal worth $3.7B sealed as Amgen buys biopharma ChemoCentryx
A company producing drugs including TAVNEOS to treat autoimmune diseases, plus others dealing with inflammatory…
August 4, 2022 - 3 minutes
Amgen
Biocartis and Amgen Shake Hands on Another Cancer Diagnostics Deal
Biocartis will use its expertise in molecular diagnostics to produce a companion diagnostic test for…
January 9, 2018 - 1 minute
Amgen Joins €50M German Fundraising for T-Cell Receptor Cancer Immunotherapy
Immatics has completed a $58M (€50M) round with the participation of Amgen, not long after both…
October 4, 2017 - 2 minutes
Scottish Shark Antibodies have caught Amgen’s Eye
Elasmogen and its partner Feldan Therapeutics have signed a research agreement with Amgen to develop…
May 9, 2017 - 2 minutes
Novartis Negotiates its Way into the US Migraine Market
Amgen and Novartis have expanded their collaboration for the co-development of their migraine drug, ensuring…
April 25, 2017 - 2 minutes
Meet One of the Most Successful German Biotech Leaders Ever
Patrick Baeuerle is the German biotech leader I wanted to interview the most (besides Simon…
April 17, 2017 - 6 minutes
German Immuno-Oncology Biotech partners up with Biotech Giant Amgen
Immatics and Amgen have inked a deal to develop bispecific drug candidates for cancer that…
January 9, 2017 - 2 minutes
€36M Fundraising to Sequence the Genome of Ireland
Genomics Medicine Ireland (GMI) has raised €36M ($40M) in series A to sequence the genome of…
October 27, 2016 - 2 minutes
€365M deal for a Danish ‘DNA barcode’ Drug Screening Platform
The giant Amgen has offered Nuevolution €365M to develop oncology and neuroscience drugs. The small Danish…
October 5, 2016 - 3 minutes
Italian Gene Therapy Biotech aims high by Collaborating with US Giant Amgen
Genenta Science and Amgen have teamed up to develop gene therapies for cancer. The Italian…
September 19, 2016 - 2 minutes
German Biotech wins FDA Approval for New Liver Cancer Trial
4SC, in Germany, has the FDA's green light to conduct efficacy trials in the US…
February 24, 2016 - 3 minutes
Can this Positive Phase III Immunotherapy End Spinal Fractures due to Osteoporosis?
UCB (Belgium) has a monoclonal antibody candidate (romozumab) which has met its primary endpoints for a…
February 22, 2016 - 3 minutes
